glp-1 drug market competition 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Receptor Agonist Market Valued
Description
Medicare explicitly excludes coverage for weight-loss medications (unless there are associated cardiovascular risks)
36,37,38 Different GLP-1RA use between studies may contribute to inconsistent findings across the studies
Moreover, the dose used to treat T2DM and obesity may differ
The problem is that GLP-1 is rapidly inactivated (half-life of approximately one minute) by the enzyme DPP-4
Supplementary Table 3
[32] Lim GE, et al
